|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.220 USD | 0.00% |
|
-3.90% | -35.84% |
| 04-23 | Grace Therapeutics Shares Fall After FDA Flags Issues in Aneurysm Treatment Application | DJ |
| 04-23 | FDA declines Grace's stroke drug over manufacturing and packaging issues, shares slump | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 2.69 | 3.33 | 3.4 |
| Spread/Res. | -17.47% | -33.33% | -34.71% |
| Spread/Supp. | +5.71% | +5.71% | +2.78% |
| Support | 2.1 | 2.1 | 2.16 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GRCE Stock
- Charts Grace Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
